Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
Autor: | Oda, Yoshiaki, Kumagai, Yuji, Kanai, Manabu, Iwama, Yasuhiro, Okura, Iori, Minamida, Takeshi, Yagi, Yukihiro, Kurosawa, Toru, Greener, Benjamin, Zhang, Ye, Walson, Judd L * |
---|---|
Zdroj: | In The Lancet Infectious Diseases April 2024 24(4):351-360 |
Databáze: | ScienceDirect |
Externí odkaz: |